MedTrace Logo

DM1 Heart Registry - DM1 Respiratory Registry

NCT01136330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 914

Last updated 2012-02-20

No results posted yet for this study

Summary

Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1 patients have an impaired prognosis (mean age of death \<60 years) due to cardiac and respiratory complications.

Our primary objective was to identify cardiac and respiratory prognostic factors in DM1.

Conditions

  • Myotonic Dystrophy

Sponsors & Collaborators

  • Institut de Myologie, France

    lead OTHER

Principal Investigators

  • Denis Duboc, MD,PhD · APHP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01136330 on ClinicalTrials.gov